None listed
Conditions
Brief summary
The trial's main purpose is to test the effectiveness of platelet-rich plasma (PRP) injections in patients who have painful gluteal tendonopathies. The trial aims to see if PRP use in patients who have gluteal tendonopathies reduces pain and improves functional levels at 12 weeks follow-up, compared to cortisone injection. No data exist on the use of PRP in gluteal tendonopathies. A small, uncontrolled study carried out by the investigators showed promising results. Therefore we want to study the use of PRP injections in patients with gluteal tendonopathy prospectively, in a double-blind randomised, controlled trial.
Interventions
A single platelet-rich plasma (PRP) injection (Biomet Biologics), injected intra-tendonously. This will be performed only once during the trial. Patents receiving the PRP procedure will have 55 mls of blood taken. The blood is placed in a balanced centrifuge and spun for 15 minutes. The resulting 7 mL (approx) of platelet-rich plasma is then injected.
Sponsors
Dr Jane Fitzpatrick
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
Trial patients can be men or women, aged between 18 and 80 years inclusive, with gluteus medius and/or minimus tendonopathy
Exclusion criteria
tears of the tendons on MRI and ultrasound, a history of breast cancer, previous hip surgery, current warfarin treatment, recent back surgery or sciatic pain, or cortisone treatment in the previous six weeks
Outcome results
None listed